Prefix Maintenance | $7,500,000 | (Apr 15, 2026)
nEye.ai | $80,000,000 | (Apr 15, 2026)
Sygaldry Technologies | $105,000,000 | (Apr 15, 2026)
Certified by Founder
Lodge
Scorpion Therapeutics
start up
- 17/07/2024
- Series C
- $150,000,000
Scorpion Therapeutics was founded to expand the reach of precision medicine to more people with cancer. The company is integrating cutting-edge technologies across target discovery, medicinal chemistry, and translational medicine to deliver Precision Oncology 2.0, a pipeline of targeted small-molecule drugs that overcome the limitations of existing treatments. Scorpion’s experienced leadership team is executing a fit-to-purpose model to efficiently unlock the next generation of precision oncology. For more information, visit scorpiontx.com.
- Industry Biotechnology Research
- Website https://www.scorpiontx.com/
- LinkedIn https://www.linkedin.com/company/scorpiontherapeutics/
Smartwage Società Benefit | $2,000,000 | (Apr 15, 2026)
Convelio | Undisclosed Amount | (Apr 15, 2026)
Neato® | $25,000,000 | (Apr 15, 2026)
Synera | $40,000,000 | (Apr 15, 2026)
Turion Space | $75,000,000 | (Apr 15, 2026)
Helical | $10,000,000 | (Apr 15, 2026)
Remission Medical | Undisclosed Amount | (Apr 14, 2026)
Slate Auto | $650,000,000 | (Apr 14, 2026)
Qoro | $750,000 | (Apr 14, 2026)